Last €24.85 EUR
Change Today -0.456 / -1.80%
Volume 0.0
VA4 On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 3:05 AM 01/29/15 All times are local (Market data is delayed by at least 15 minutes).

vascular solutions inc (VA4) Snapshot

Open
€24.93
Previous Close
€25.30
Day High
€24.93
Day Low
€24.85
52 Week High
01/27/15 - €25.58
52 Week Low
05/21/14 - €13.56
Market Cap
426.8M
Average Volume 10 Days
10.0
EPS TTM
--
Shares Outstanding
17.2M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for VASCULAR SOLUTIONS INC (VA4)

Related News

No related news articles were found.

vascular solutions inc (VA4) Related Businessweek News

No Related Businessweek News Found

vascular solutions inc (VA4) Details

Vascular Solutions, Inc., a medical device company, provides various solutions to interventional cardiologists, interventional radiologists, electro physiologists, and vein practices worldwide. The company’s catheter products include GuideLiner catheters for deep-seating, back-out support, and optimal stenting in various interventions; Pronto extraction catheters for treating acute myocardial infarction; Micro-Introducers for performing arterial and venous catheterization procedures; Langston to measure intravascular pressure gradients for the diagnosis of aortic valve stenosis; and SmartNeedle, a doppler-guided needle device designed to provide auditory ultrasound-guided access to arteries and veins. It also offers Venture, a deflectable tip catheter used for steering guidewires in various interventions; Guardian, a hemostat valve used in catheterization procedures; SuperCross, a microcatheter for support and delivery of guidewires during coronary and peripheral catheterization procedures; Snares to retrieve or manipulate objects in the cardiovascular system; and Minnie, a support catheter used to facilitate placement and exchange of guidewires and other interventional devices. In addition, the company provides hemostat products comprising D-Stat Dry Thrombix, a thrombin-based hemostat bandage used to control bleeding at the site of femoral artery punctures; D-Stat Flowable, a flowable mixture to control bleeding in the pectoral pockets; Vasc Band radial hemostat, a compression device used to assist with bleeding control; D-Stat Radial, a wrist band to control bleeding at the radial artery access site; and accumed wrist positioning splint. Further, it offers vein products and services, such as Vari-Lase endovenous laser, a laser console and procedure kit used for the treatment of varicose veins, as well as a reprocessing service for the ClosureFAST radiofrequency vein ablation catheter. The company was founded in 1996 and is headquartered in Minneapolis, Minnesota.

406 Employees
Last Reported Date: 02/4/14
Founded in 1996

vascular solutions inc (VA4) Top Compensated Officers

Co-Founder, Chief Executive Officer and Direc...
Total Annual Compensation: $500.0K
Chief Financial Officer, Senior Vice Presiden...
Total Annual Compensation: $265.0K
Senior Vice President of Operations
Total Annual Compensation: $340.0K
Senior Vice President of Worldwide Sales
Total Annual Compensation: $280.0K
Vice President of Marketing
Total Annual Compensation: $250.0K
Compensation as of Fiscal Year 2013.

vascular solutions inc (VA4) Key Developments

Vascular Solutions Inc. Announces Preliminary Revenue Results for the Fourth Quarter and Full Year Ended December 31, 2014; Revises Earnings Guidance for the Fourth Quarter 2014

Vascular Solutions Inc. announced preliminary revenue results for the fourth quarter and full year ended December 31, 2014. The company announced that fourth quarter revenue is expected to be $33.6 million, an increase of 15.5% from $29.1 million in the year-earlier quarter, exceeding the top-end of the company's guidance range of $32.5 million to $33.5 million for the quarter. On a preliminary, unaudited basis for the fourth quarter, U.S. revenues grew 8% to $26.8 million, while international revenues grew nearly 59% to $6.7 million. The company announced that For the full year 2014, revenue is expected to be $126.1 million, an increase of 14% from 2013 revenue of $110.5 million. The company expects GAAP net earnings for the fourth quarter 2014 will be above the high end of the company's previous GAAP net earnings guidance of $0.16 to $0.18 per fully diluted share.

Vascular Solutions, Inc. Announces FDA 510(K) Clearance of Zigiwire Access Guidewire System

Vascular Solutions Inc. announced that the ZigiWire access support guidewire system has received FDA 510(k) clearance. The company is designed to facilitate placement and exchange of catheters during peripheral diagnostic or interventional procedures. The company plans to launch ZigiWire through its 101-member direct U.S. sales force in January 2015. ZigiWire is manufactured for the company by VadisWire Corp. The ZigiWire guidewire support systems employ a novel method of establishing progressive and secure support wire access into most arterial vascular anatomy in an efficient and time saving manner. Through any standard 0.038" compatible catheter lumen, the operator advances a floppy-style lead wire for initial engagement of the target vessel which is then followed by up to two additional wires to achieve the desired level of guidewire support.

Vascular Solutions Receives FDA Clearance for VSI Radial Introducer Sheath

Vascular Solutions Inc. has received the FDA 510(k) clearance for VSI Radial introducer sheath for use in the introduction of guidewires and catheters into a vein or artery. The VSI Radial introducer sheath is specifically designed for patients undergoing transradial catheterization rocedures. Vascular Solutions plans to launch the VSI Radial introducer sheath through its 101-member direct US sales force in January 2015. The VSI Radial introducer sheath is manufactured for Vascular Solutions by LePu Medical Technology (Beijing) Co. Ltd. under an exclusive US distribution agreement. All 17 models of the VSI Radial introducer sheath contain a hydrophilic-coated introducer sheath and dilator, and the device will be available in three kit options. The Standard Kit option, designed for the single-wall micro-puncture technique, consists of 9 models that include a sheath, dilator, guidewire and 21G needle. The Access Kit option, designed for the double-wall micro-puncture technique consists of six models that include a sheath, dilator, polymer-coated guidewire, IV catheter needle, and syringe. The 035 Kit option, designed for converting a 4F or 5F diagnostic procedure into a 6F interventional procedure, consists of two models that include a sheath, dilator and 0.035 guidewire.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VA4:GR €24.85 EUR -0.456

VA4 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AtriCure Inc $19.92 USD -0.06
CryoLife Inc $11.51 USD -0.24
Endologix Inc $14.23 USD -0.27
LeMaitre Vascular Inc $7.90 USD +0.10
STAAR Surgical Co $5.71 USD -0.07
View Industry Companies
 

Industry Analysis

VA4

Industry Average

Valuation VA4 Industry Range
Price/Earnings 42.1x
Price/Sales 4.1x
Price/Book 4.6x
Price/Cash Flow 36.2x
TEV/Sales 3.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VASCULAR SOLUTIONS INC, please visit www.vascularsolutions.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.